FDA Bets Big on AI—Because Paperwork Was Too Efficient Already
11
2
Bureaucracy meets algorithms as the FDA unveils its AI ’modernization’ push. Because nothing screams innovation like government-approved machine learning.
Subheader: Silicon Valley’s Playbook Infiltrates DC
The agency’s new platform promises to ’streamline’ processes—translation: fewer human errors, same glacial pace. Wall Street analysts predict a 0.0001% efficiency gain, immediately priced into biotech stocks.
Bonus jab: Meanwhile, crypto exchanges process 10,000x the transactions with 1/100th the oversight. Priorities, people.
Generally Intelligent Newsletter
A weekly AI journey narrated by Gen, a generative AI model.Your EmailGet it!Get it!
By:
